DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

Abbott Laboratories (NYSE: ABT)

47.12 0.49 (1.05%)

REAL-TIME: Last trade at

Extended Hours: $47.19 $0.07 (0.15%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

ABT $47.12 1.05%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.94
Previous Close $46.63
Daily Range $46.72 - $47.28
52-Week Range $37.78 - $47.88
Market Cap $71.1B
P/E Ratio 41.63
Dividend (Yield) $0.96 (2.1%)
Ex-Dividend Date
Dividend Pay Date
04/13/15
05/15/15
Volume 8,488,526
Average Daily Volume 4,546,385
Current FY EPS $2.15

Sector

Healthcare

Industry

Drug Makers

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website: http://www.abbott.com/

News & Commentary Rss Feed

Is AbbVie Inc. Stock About to Crash?

AbbVie has been an amazing growth story since its inception in 2013. However, this trend might be about to come to abrupt end. Here's why.

Pre-Market Earnings Report for April 22, 2015 : KO, BA, MCD, ABT, TMO, EMC, BK, TEL, TROW, STJ, APH

Pre-Market Earnings Report for April 22, 2015 : KO, BA, MCD, ABT, TMO, EMC, BK, TEL, TROW, STJ, APH, NLSN

Abbott Laboratories (ABT) Stock Advances Today Ahead of Wednesday's Earnings Release

3 Health Services Stocks Moving The Industry Upward

Abbott Labs Reports First Quarter Earnings On Wednesday And Here Are My Thoughts

Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syn

Pharmacological Advancements in Neuroscience Drug Discovery & Pre-Clinical Studies for Fragile X Syndrome to Identify Drug Candidates for Autism Therapies Lead Biotech Sector Research

Chasing High Dividend Growth Rates For Lower Total Returns

Rosetta Genomics Shares Upgraded At Cantor

Next Week In Biotech: Amgen, AbbVie, Biogen Earnings, UniQure CHMP, AAN Meeting

Notable ETF Outflow Detected - SSO, ABT, ABBV, ACN

See More ABT News...

ABT's Top Competitors

ABT $47.12 (1.05%)
Current stock: ABT
NVS $104.07 (1.79%)
Current stock: NVS
PFE $34.89 (-0.34%)
Current stock: PFE
JNJ $100.30 (0.09%)
Current stock: JNJ